Cambiar Investors LLC Reduces Stock Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

Cambiar Investors LLC lessened its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 7.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 24,550 shares of the company’s stock after selling 2,105 shares during the quarter. Cambiar Investors LLC owned about 0.16% of U.S. Physical Therapy worth $2,178,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. The Manufacturers Life Insurance Company grew its stake in shares of U.S. Physical Therapy by 4.5% during the second quarter. The Manufacturers Life Insurance Company now owns 7,248 shares of the company’s stock valued at $670,000 after acquiring an additional 309 shares in the last quarter. Handelsbanken Fonder AB boosted its holdings in U.S. Physical Therapy by 25.0% in the third quarter. Handelsbanken Fonder AB now owns 3,000 shares of the company’s stock valued at $254,000 after purchasing an additional 600 shares during the last quarter. Creative Planning acquired a new stake in U.S. Physical Therapy during the 3rd quarter valued at approximately $252,000. NBC Securities Inc. increased its holdings in U.S. Physical Therapy by 8.0% during the 3rd quarter. NBC Securities Inc. now owns 8,523 shares of the company’s stock worth $721,000 after purchasing an additional 633 shares during the last quarter. Finally, Penn Davis Mcfarland Inc. acquired a new position in shares of U.S. Physical Therapy in the 3rd quarter valued at approximately $2,552,000.

Wall Street Analyst Weigh In

Several research firms have recently commented on USPH. Citizens Jmp upgraded U.S. Physical Therapy to a “strong-buy” rating in a research note on Monday, December 16th. JMP Securities began coverage on shares of U.S. Physical Therapy in a report on Monday, December 16th. They set an “outperform” rating and a $113.00 price objective for the company. Bank of America upgraded shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and upped their target price for the company from $100.00 to $115.00 in a research note on Monday, December 16th. JPMorgan Chase & Co. lifted their price target on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 3rd. Finally, Barrington Research restated an “outperform” rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a research note on Thursday, November 21st. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, U.S. Physical Therapy currently has a consensus rating of “Buy” and an average target price of $114.00.

U.S. Physical Therapy Trading Up 0.1 %

U.S. Physical Therapy stock opened at $87.48 on Wednesday. U.S. Physical Therapy, Inc. has a 1 year low of $76.18 and a 1 year high of $113.63. The firm’s 50-day moving average is $90.58 and its 200-day moving average is $88.19. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The company has a market cap of $1.32 billion, a P/E ratio of 93.06, a PEG ratio of 3.61 and a beta of 1.48.

Insiders Place Their Bets

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of the stock in a transaction on Monday, December 9th. The stock was sold at an average price of $96.25, for a total value of $49,665.00. Following the sale, the chief financial officer now directly owns 20,469 shares of the company’s stock, valued at $1,970,141.25. This trade represents a 2.46 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.70% of the stock is currently owned by corporate insiders.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.